Flaxseed Lowers High Cholesterol In Men: Iowa State NWRC Study

A new study from Iowa State University’s Nutrition and Wellness Research Center (NWRC) may give men a way to combat high cholesterol without drugs — if they don’t mind sprinkling some flaxseed into their daily diet. Suzanne Hendrich, an ISU professor in food science and human nutrition, led a study that examined the effects of [...]

State HIV Programs Face Cuts, CDC Notes High Prevalence In Young African-Americans, Gay Men

NPR’s Shots blog: “As states struggle with budget shortfalls, many are looking to trim costs by chopping health spending. And funding for HIV/AIDS programs has been a prime target. A proposed budget in South Carolina would eliminate funding for HIV/AIDS prevention and for help with buying drugs to treat the disease…

FDA Alerts Consumers of Raw Milk Danger

WASHINGTON (MedPage Today) — An outbreak of campylobacteriosis has prompted the FDA and several Midwestern state health agencies to warn consumers against drinking unpasteurized, raw milk.

2010 BIO International Convention To Feature Full Lineup Of International Programming

The Biotechnology Industry Organization (BIO) today announces that Wednesday, May 5th has been named International Day, and will include a special programming track on Global Biotechnology Issues. International Case Studies will be presented throughout the week on topics such as breakthroughs in molecular diagnostics, biomarkers, dementia and Alzheimer’s, and translational R&D…

Erbitux can now be used in Japan as 1st-line treatment for mCRC: Merck Serono

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that Erbitux® (cetuximab) can now be used in Japan in combination with chemotherapy in the 1st-line treatment for patients with epidermal growth factor receptor -expressing, curatively unresectable (inoperable), advanced or recurrent colorectal cancer carrying the KRAS wildtype gene.

Scientists link gene expression profiling effort to identify potential novel therapeutic for ALS

In an article published in Nature Genetics today, scientists at the ALS Therapy Development Institute describe how they have linked an unbiased gene expression profiling effort to the identification and successful preclinical testing of a potential novel therapeutic for amyotrophic lateral sclerosis.

Cortex signs agreement to sell certain AMPAKINE compounds to Biovail

Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL in which Biovail acquired certain AMPAKINE compounds and the rights to the patent filing for respiratory depression and vaso-occlusive crises associated with sickle cell disease.

New data on EHT 0202 for treatment of patients with AD presented at Geneva/Springfield Symposium

ExonHit Therapeutics announced today that promising new data on EHT 0202, its lead candidate in Alzheimer’s disease, were presented at the 11th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy from March 24th to March 27th in Geneva, Switzerland.

Two-drug combination destroys precancerous colon polyps

A two-drug combination destroys precancerous colon polyps with no effect on normal tissue, opening a new potential avenue for chemoprevention of colon cancer, a team of scientists at The University of Texas M. D. Anderson Cancer Center reports in the advance online edition of the journal Nature.

Pharmacy Practice Model Summit Announced

An invitational consensus conference will be held on November 7 - 9, 2010, in Dallas as part of the ASHP and ASHP Foundation’s Pharmacy Practice Model Initiative. The conference will bring together thought leaders throughout hospital and health-system pharmacy to reach consensus on optimal practice models that are based on the effective use of [...]